Influence of Older Age and Other Risk Factors on Pneumonia Hospitalization in Switzerland in the Pneumococcal Vaccine Era.

Werner C Albrich, Frank Rassouli, Frederike Waldeck, Christoph Berger, Florent Baty
Author Information
  1. Werner C Albrich: Division Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  2. Frank Rassouli: Department of Pulmonary and Sleep Medicine, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  3. Frederike Waldeck: Division Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  4. Christoph Berger: Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zürich, Zurich, Switzerland.
  5. Florent Baty: Department of Pulmonary and Sleep Medicine, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.

Abstract

Pneumococcal pneumonia is a disease of the extremes of age. However, as other traditional risk factors for pneumococcal pneumonia also increase with older age, it is unclear if older age itself should be an indication for pneumococcal vaccination. Therefore, we assessed the effect of age on risk for hospitalization for pneumonia and for pneumococcal pneumonia. Using a national hospitalization dataset, all patients ≥16 years hospitalized in a Swiss hospital with a diagnosis of pneumonia or pneumococcal pneumonia between 2002 and 2015 were included. Multivariable logistic regression analysis was used to test the association between age (≥50 or ≥65 years) and hospitalization for pneumonia or pneumococcal pneumonia after adjusting for pneumococcal vaccine indications. Similar analyses were performed for effect of age on length of stay (LOS) and mortality. Among a total of 17,619,016 hospitalizations a diagnosis of pneumonia was present in 421,760 (2.4%) and a diagnosis of pneumococcal pneumonia in 21,610 (0.12%). Age ≥50 years (OR: 3.52 and 2.12, respectively; for both <0.001) and age ≥65 years (OR: 2.98 and 1.80, respectively; for both <0.001) as well as most Swiss pneumococcal vaccine indications were independent predictors of hospitalization with a pneumonia and pneumococcal pneumonia diagnosis, respectively. Older age with both age cut-offs were associated with increased LOS (≥50 years: aRR: 1.19 and 1.24, respectively; age ≥65 years: aRR: 1.60 and 1.20, respectively; < 0.001 for all) and mortality (≥50 years: aOR: 4.73 and 2.84, respectively; age ≥65 years: aOR: 2.38 and 2.69, respectively, < 0.001 for all) in patients with a pneumonia and pneumococcal pneumonia diagnosis, respectively. The effects of pneumococcal vaccine indications decreased with older age. The incidences of hospitalizations with a pneumonia diagnosis and a pneumococcal pneumonia diagnosis increased significantly from the pre-vaccine era to the PCV7 era and the PCV13 era ( for trend for both analyses <0.001). This study confirms the Swiss indications for pneumococcal vaccination as independent risk factors for pneumonia hospitalizations. Older age itself should be considered as an additional vaccine indication. Pneumonia and pneumococcal pneumonia in adults have increased despite pneumococcal vaccination in children.

Keywords

References

  1. Thorax. 2018 Mar;73(3):262-269 [PMID: 28988217]
  2. Pneumonia (Nathan). 2016 Jun 27;8:9 [PMID: 28702288]
  3. Emerg Infect Dis. 2001 Jan-Feb;7(1):92-9 [PMID: 11266299]
  4. N Engl J Med. 2013 Jul 11;369(2):155-63 [PMID: 23841730]
  5. Lancet. 2015 Jan 10;385(9963):117-71 [PMID: 25530442]
  6. N Engl J Med. 2014 Oct 23;371(17):1619-28 [PMID: 25337751]
  7. Eur J Clin Microbiol Infect Dis. 2015 Sep;34(9):1839-47 [PMID: 26059041]
  8. CMAJ. 2009 Jan 6;180(1):48-58 [PMID: 19124790]
  9. PLoS One. 2017 Sep 7;12(9):e0184204 [PMID: 28880953]
  10. Lancet. 2007 Apr 7;369(9568):1179-86 [PMID: 17416262]
  11. Vaccine. 2017 Dec 18;35(51):7107-7113 [PMID: 29146381]
  12. Clin Infect Dis. 2011 May;52 Suppl 4:S296-304 [PMID: 21460288]
  13. Thorax. 2012 Jan;67(1):71-9 [PMID: 20729232]
  14. Vaccine. 2014 Sep 8;32(40):5185-91 [PMID: 25077419]
  15. Expert Rev Vaccines. 2016;15(3):279-93 [PMID: 26651847]
  16. Open Forum Infect Dis. 2015 Mar 20;2(1):ofv020 [PMID: 26034770]
  17. Lancet Respir Med. 2014 May;2(5):387-94 [PMID: 24815804]
  18. BMC Infect Dis. 2015 Oct 30;15:470 [PMID: 26515134]
  19. Open Forum Infect Dis. 2014 May 27;1(1):ofu024 [PMID: 25734097]
  20. Vaccine. 2008 Sep 8;26(38):4947-54 [PMID: 18662735]
  21. Clin Infect Dis. 2004 Jul 15;39(2):170-2 [PMID: 15307024]
  22. Clin Infect Dis. 2019 May 17;68(11):1831-1838 [PMID: 30239637]
  23. Expert Rev Vaccines. 2019 Apr;18(4):327-341 [PMID: 30759352]
  24. Clin Infect Dis. 2008 Dec 1;47 Suppl 3:S202-6 [PMID: 18986290]
  25. Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1524-1529 [PMID: 28154145]
  26. Clin Infect Dis. 2017 Sep 01;65(5):787-795 [PMID: 29017280]
  27. Clin Infect Dis. 2015 Sep 15;61(6):927-33 [PMID: 26066319]

Word Cloud

Created with Highcharts 10.0.0pneumoniapneumococcalagerespectivelydiagnosis2hospitalizationvaccine0011years≥50≥65indicationsyears:riskolderindicationvaccinationSwisshospitalizations0<0OlderincreasederaPneumococcalfactorseffectpatientsanalysesLOSmortalityAgeOR:independentaRR:<aOR:PneumoniadiseaseextremesHowevertraditionalalsoincreaseunclearThereforeassessedUsingnationaldataset≥16hospitalizedhospital20022015includedMultivariablelogisticregressionanalysisusedtestassociationadjustingSimilarperformedlengthstayAmongtotal17619016present4217604%2161012%352129880wellpredictorscut-offsassociated19246020473843869effectsdecreasedincidencessignificantlypre-vaccinePCV7PCV13trendstudyconfirmsconsideredadditionaladultsdespitechildrenInfluenceRiskFactorsHospitalizationSwitzerlandVaccineEraincidencepneumococcus

Similar Articles

Cited By